{"id":7911,"date":"2023-09-26T10:14:47","date_gmt":"2023-09-26T08:14:47","guid":{"rendered":"https:\/\/old.grancreo.com\/?p=7911"},"modified":"2024-10-08T12:53:46","modified_gmt":"2024-10-08T10:53:46","slug":"stav-nasich-cev-predpovida-jak-dlouho-si-udrzime-zivot-ve-zdravi-cim-dele-si-udrzime-zivot-ve-zdravi-tim-dele-budeme-zit","status":"publish","type":"post","link":"https:\/\/old.grancreo.com\/cs\/blog\/stav-nasich-cev-predpovida-jak-dlouho-si-udrzime-zivot-ve-zdravi-cim-dele-si-udrzime-zivot-ve-zdravi-tim-dele-budeme-zit\/","title":{"rendered":"Stav na\u0161ich c\u00e9v p\u0159edpov\u00edd\u00e1, jak dlouho si udr\u017e\u00edme \u017eivot ve zdrav\u00ed. \u010c\u00edm d\u00e9le si udr\u017e\u00edme \u017eivot ve zdrav\u00ed, t\u00edm d\u00e9le budeme \u017e\u00edt."},"content":{"rendered":"\n

P\u0159ed n\u011bkolika t\u00fddny vydal evropsk\u00fd statistick\u00fd \u00fa\u0159ad informaci, kter\u00e1 \u010cechov nepot\u011b\u0161ila. V pr\u016fm\u011bru se \u010ce\u0161i do\u017e\u00edvaj\u00ed ve zdrav\u00ed pouze do 61. roku sv\u00e9ho \u017eivota. To znamen\u00e1, \u017ee po dosa\u017een\u00ed tohoto v\u011bku se u n\u00e1s za\u010dnou objevovat z\u00e1va\u017en\u00e1 chronick\u00e1 onemocn\u011bn\u00ed. Pr\u016fm\u011brn\u00fd v\u011bk do\u017eit\u00ed mu\u017ee \u010cecha je 76 let, u \u017een je to asi o 4 roky v\u00edce. To znamen\u00e1, \u017ee prakticky posledn\u00edch n\u011bkolik let pracovn\u00edho \u017eivota a celou penzijn\u00ed dobu p\u0159e\u017eijeme u\u017e jen s v\u00e1\u017en\u00fdmi chorobami. H\u016f\u0159e na tom v EU jsou pouze pobaltsk\u00e9 st\u00e1ty. Jen pro n\u00e1zornost, \u0160v\u00e9dov\u00e9 se pr\u016fm\u011brn\u011b ve zdrav\u00ed do\u017e\u00edvaj\u00ed a\u017e 70 let a pr\u016fm\u011brnou d\u00e9lku \u017eivota maj\u00ed 84 let. Jinak \u0159e\u010deno, pokud se u \u0160v\u00e9d\u016f teprve za\u010d\u00ednaj\u00ed objevovat chronick\u00e1 onemocn\u011bn\u00ed, \u010ce\u0161i v t\u00e9 dob\u011b u\u017e za\u010d\u00ednaj\u00ed um\u00edrat. Zn\u00ed to hroziv\u011b, ale takov\u00e1 jsou fakta.<\/p>\n\n\n\n

Nej\u010dast\u011bj\u0161\u00ed p\u0159\u00ed\u010dinou \u00famrt\u00ed \u010cech\u016f je n\u00e1sledek dlouhodob\u011b \u0161patn\u00e9ho stavu c\u00e9v.<\/strong><\/h2>\n\n\n\n

Statistika tak\u00e9 \u0159\u00edk\u00e1, \u017ee t\u00e9m\u011b\u0159 polovina v\u0161ech \u00famrt\u00ed v \u010cesku je z d\u016fvodu srde\u010dn\u00edho infarktu, n\u00e1hl\u00e9ho srde\u010dn\u00edho selh\u00e1n\u00ed nebo mozkov\u00e9 mrtvice. Ano spr\u00e1vn\u011b tu\u0161\u00edte, v\u0161echny maj\u00ed souvislost s na\u0161\u00edm ob\u011bhov\u00fdm (c\u00e9vn\u00edm) syst\u00e9mem. Na vin\u011b je dlouhodob\u011b \u0161patn\u00fd stav na\u0161ich c\u00e9v. C\u00e9vy jsou pam\u011b\u0165 na\u0161eho zdrav\u00ed, nemoc\u00ed i zlozvyk\u016f a neodpou\u0161t\u011bj\u00ed nic. Co se v na\u0161ich c\u00e9v\u00e1ch d\u011bje?<\/p>\n\n\n\n

Stav c\u00e9vn\u00ed v\u00fdstelky (endotel) a pru\u017enost c\u00e9v ur\u010duj\u00ed, jak dlouho si udr\u017e\u00edme zdrav\u00ed a zda si prodlou\u017e\u00edme v\u011bk do\u017eit\u00ed. Z\u00e1kladem je zabr\u00e1nit rozvoji ateroskler\u00f3zy.<\/strong><\/h2>\n\n\n\n

Za to, aby c\u00e9vy dob\u0159e fungovaly, byly pru\u017en\u00e9, nezan\u00e1\u0161ely se, nekornat\u011bly a nezhrubly, je zodpov\u011bdn\u00e1 pouze a jen jejich vnit\u0159n\u00ed v\u00fdstelka (lat. endotel). Endotel tvo\u0159\u00ed pouze jedna jedin\u00e1 vrstva ploch\u00fdch (dla\u017edicovit\u00fdch) bun\u011bk, kter\u00e9 pokr\u00fdvaj\u00ed vnit\u0159n\u00ed st\u011bnu c\u00e9vy. Zdrav\u00fd endotel je dokonale hladk\u00fd, chr\u00e1n\u00ed st\u011bnu c\u00e9vy p\u0159ed po\u0161kozen\u00edm. T\u00edm si c\u00e9vn\u00ed st\u011bna zachov\u00e1v\u00e1 svoji nejd\u016fle\u017eit\u011bj\u0161\u00ed vlastnost \u2013 pru\u017enost. Pru\u017enost c\u00e9v se v\u011bkem p\u0159irozen\u011b sni\u017euje, av\u0161ak mnohem v\u00edce si ji zhor\u0161ujeme na\u0161\u00edm \u017eivotn\u00edm stylem, zejm\u00e9na stravov\u00e1n\u00edm, po\u017e\u00edv\u00e1n\u00edm alkoholu nebo kou\u0159en\u00edm, prost\u011b neduhy. Co se vlastn\u011b s v\u00fdstelkou (endotelem) c\u00e9vy d\u011bje?<\/p>\n\n\n\n

Pr\u016f\u0159ez st\u011bnou c\u00e9vy, endotel (endothelial) je vnit\u0159n\u00ed jedna vrstva bun\u011bk<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n

Stav jedin\u00e9 vrstvy bun\u011bk (endotelu) m\u016f\u017ee rozhodnout o na\u0161em budouc\u00edm zdrav\u00ed.<\/strong><\/h2>\n\n\n\n

Endotel c\u00e9vy si p\u0159edstavme nap\u0159\u00edklad jako chodn\u00edkovou dla\u017ebu. Pokud je neporu\u0161en\u00e1, nevad\u00ed j\u00ed \u017e\u00e1dn\u00e1 voda, \u0161p\u00edna, oleje, teplo, mr\u00e1z, prost\u011b nic. Objev\u00ed-li se v n\u00ed v\u0161ak i jen mal\u00e9 trhliny \u010di praskliny (nap\u0159. po\u010das\u00edm, opot\u0159eben\u00edm, p\u0159et\u011b\u017eov\u00e1n\u00edm, po\u0161kozov\u00e1n\u00edm), za\u010dne se v nich zachyt\u00e1vat a usazovat ne\u010distota. Ta se dost\u00e1v\u00e1 p\u0159es trhliny pod dla\u017ebu a eroduje podlo\u017e\u00ed. V\u00fdsledkem je postupn\u00fd rozpad dla\u017eby a chodn\u00edku. P\u0159esn\u011b to se d\u011bje p\u0159i po\u0161kozen\u00ed c\u00e9vn\u00edho endotelu. Nejprve se objev\u00ed drobn\u00e1 po\u0161kozen\u00ed (lat. l\u00e9ze), kter\u00e1 se \u010dasem zv\u011bt\u0161uj\u00ed. Jsou zp\u016fsobeny dlouhodob\u00fdm mikroz\u00e1n\u011btem endotelu. Pod zan\u00edcen\u00fd endotel se do c\u00e9vn\u00ed st\u011bny dost\u00e1vaj\u00ed r\u016fzn\u00e9 b\u00edl\u00e9 krvinky, \u201e\u0161patn\u00fd\u201c cholesterol a r\u016fzn\u00e9 tukov\u00e9 l\u00e1tky. St\u011bna c\u00e9vy za\u010dne hrubnout, ztr\u00e1c\u00ed pru\u017enost a zmen\u0161uje se pr\u016fsvit (lumen) c\u00e9vy. V medic\u00edn\u011b se tento chorobn\u00fd proces v c\u00e9v\u00e1ch ozna\u010duje jako ateroskler\u00f3za (laicky ozna\u010dovan\u00fd tak\u00e9 jako kornat\u011bn\u00ed) a v\u011bkem se p\u0159irozen\u011b m\u016f\u017ee objevit. Nejv\u011bt\u0161\u00ed vliv na jej\u00ed rozvoj v\u0161ak maj\u00ed ji\u017e v\u00fd\u0161e zm\u00edn\u011bn\u00e9 neduhy (zejm\u00e9na strava, stres, alkohol a nikotin), ale i nap\u0159. cukrovka \u010di zv\u00fd\u0161en\u00fd krevn\u00ed tlak. To, co za\u010dalo jako drobn\u00e9 po\u0161kozen\u00ed endotelu, m\u016f\u017ee po dlouh\u00fdch letech skon\u010dit jako rozs\u00e1hl\u00e1 c\u00e9vn\u00ed ateroskler\u00f3za se z\u00e1va\u017en\u00fdm z\u00fa\u017een\u00edm c\u00e9vn\u00edho pr\u016ftoku krve. Ateroskler\u00f3za p\u0159\u00edtomn\u00e1 ve velk\u00fdch srde\u010dn\u00edch nebo kr\u010dn\u00edch tepn\u00e1ch, to u\u017e je jen \u201ena skok\u201c k infarktu nebo mrtvici. A tady se vrac\u00edme ke statistice z \u00favodu \u010dl\u00e1nku, pro\u010d Slov\u00e1ci um\u00edraj\u00ed tak brzy. Jak jste si mohli p\u0159e\u010d\u00edst, odpov\u011b\u010f najdeme v na\u0161ich c\u00e9v\u00e1ch, konkr\u00e9tn\u011b ve stavu jejich endotelu a pru\u017enosti. Co s t\u00edm m\u016f\u017eeme ud\u011blat?<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n

AtheroControl \u2013 prokazateln\u011b zlep\u0161uje stav ob\u011bhov\u00e9ho syst\u00e9mu, endotelu a pru\u017enosti c\u00e9v.<\/strong><\/h2>\n\n\n\n

Slovensko-italsk\u00e1 spole\u010dnost PHARCO GRANCREO p\u0159inesla na trh v lo\u0148sk\u00e9m roce inovativn\u00ed produkt AtheroControl. M\u00e1 komplexn\u00ed slo\u017een\u00ed zam\u011b\u0159en\u00e9 na zlep\u0161en\u00ed endotelu, zm\u00edrn\u011bn\u00ed rozvoje ateroskler\u00f3zy a zv\u00fd\u0161en\u00ed pru\u017enosti c\u00e9v. Ned\u00e1vno vy\u0161ly v\u00fdsledky z p\u0159evratn\u00e9ho a pravd\u011bpodobn\u011b sv\u011btov\u011b jedine\u010dn\u00e9ho klinick\u00e9ho testov\u00e1n\u00ed produktu AtheroControl. AtheroControl byl c\u00edlen\u011b zkou\u0161en u lid\u00ed l\u00e9\u010den\u00fdch na zv\u00fd\u0161en\u00fd krevn\u00ed tlak (hypertenze). Hlavn\u00edm c\u00edlem bylo zjistit, zda AtheroControl dok\u00e1\u017ee zlep\u0161it vybran\u00e9 parametry, kter\u00e9 ukazuj\u00ed na stav endotelu a pru\u017enosti c\u00e9v. Jak to dopadlo?<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n\n

V\u00fdsledky testov\u00e1n\u00ed produktu AtheroControl (srpen 2023, CARDIOCARE, Bratislava)<\/strong><\/h2>\n\n\n\n

AtheroControl prok\u00e1zal v testech v\u00fdznamn\u00e9 zlep\u0161en\u00ed dvou kl\u00ed\u010dov\u00fdch parametr\u016f. Oba parametry jsou medic\u00ednsky prokazateln\u011b prov\u00e1z\u00e1ny se stavem endotelu a pru\u017enost\u00ed c\u00e9v (cel\u00e9ho ob\u011bhov\u00e9ho syst\u00e9mu). Jinak \u0159e\u010deno, dok\u00e1\u017eeme-li je zlep\u0161it, zlep\u0161\u00edme i n\u00e1\u0161 endotel a pru\u017enost c\u00e9v.<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>\n\n
\n
\"\"<\/figure>\n<\/div>\n\n\n

Ve zkou\u0161en\u00ed byli zahrnuti v\u00fdlu\u010dn\u011b lid\u00e9 l\u00e9\u010den\u00ed na vysok\u00fd krevn\u00ed tlak. Pr\u00e1v\u011b oni maj\u00ed zv\u00fd\u0161en\u00e9 riziko infarktu nebo mrtvice. Studie tak\u00e9 uk\u00e1zala na velmi z\u00e1va\u017en\u00fd a z\u0159ejm\u011b dosud nepotvrzen\u00fd fakt. V\u0161ichni (100%) pacient\u016f, p\u0159esto\u017ee byli dob\u0159e l\u00e9\u010deni na vysok\u00fd krevn\u00ed tlak (hypertenze), m\u011bli ve \u0161patn\u00e9m stavu c\u00e9vn\u00ed endotel. Jinak \u0159e\u010deno, l\u00e9\u010dba hypertenze jim sice upravila krevn\u00ed tlak, ale nem\u011bla prakticky \u017e\u00e1dn\u00fd vliv na zlep\u0161en\u00ed stavu endotelu a pru\u017enosti c\u00e9v. Dokazuje to i \u017eivotn\u00ed realita. P\u0159esto\u017ee ka\u017ed\u00fdm rokem v populaci p\u0159ib\u00fdv\u00e1 v\u00edce pacient\u016f dob\u0159e l\u00e9\u010den\u00fdch na hypertenzi, nekles\u00e1 po\u010det \u00famrt\u00ed na infarkt nebo mrtvici. Naopak tento po\u010det st\u00e1le roste, jde o medic\u00ednsk\u00fd paradox. Pr\u00e1v\u011b proto byl AteroControl zkou\u0161en, jestli dok\u00e1\u017ee tento paradox omezit. V\u00fdsledky ukazuj\u00ed, \u017ee ano.<\/p>\n\n\n\n

M\u016f\u017eeme nad v\u0161echny pochybnosti hypertonik\u016fm garantovat, \u017ee u\u017e\u00edv\u00e1n\u00ed produktu AtheroControl 1 tableta ve\u010der po dobu 3 m\u011bs\u00edc\u016f jim v\u00fdznamn\u011b zlep\u0161\u00ed stav ob\u011bhov\u00e9ho syst\u00e9mu a sn\u00ed\u017e\u00ed riziko infarktu nebo mrtvice.<\/p>\n\n\n\n

Ve zkou\u0161en\u00ed se u\u017e\u00edval AtheroControl 1 tableta ve\u010der po dobu t\u0159\u00ed m\u011bs\u00edc\u016f. Pr\u00e1v\u011b lid\u00e9 se zv\u00fd\u0161en\u00fdm krevn\u00edm tlakem (hypertonici) budou nejv\u00edce profitovat ze zlep\u0161en\u00ed endotelu a pru\u017enosti c\u00e9v. Z\u00e1rove\u0148 se takto prok\u00e1zala i bezpe\u010dnost soub\u011b\u017en\u00e9ho u\u017e\u00edv\u00e1n\u00ed l\u00e9k\u016f na krevn\u00ed tlak a produktu AtheroControl. Jednodu\u0161e \u0159e\u010deno, AtheroControl neovlivnil l\u00e9\u010dbu krevn\u00edho tlaku u u\u017eivatel\u016f. Dal\u0161\u00edm d\u016fkazem p\u0159\u00edm\u00e9ho \u00fa\u010dinku produktu AtheroControl na endotel a pru\u017enost c\u00e9v je skute\u010dnost, \u017ee u u\u017eivatel\u016f ve studii nedo\u0161lo k v\u00fdznamn\u00e9 zm\u011bn\u011b t\u011blesn\u00e9 hmotnosti. Jinak \u0159e\u010deno, nen\u00ed mo\u017en\u00e9 zlep\u0161en\u00ed endotelu a pru\u017enosti c\u00e9v p\u0159ipsat zm\u011bn\u011b t\u011blesn\u00e9 v\u00e1hy, nebo\u0165 k \u017e\u00e1dn\u00e9 v\u00fdznamn\u00e9 zm\u011bn\u011b nedo\u0161lo. U\u017eivatel\u00e9 byli vyzv\u00e1ni, aby nem\u011bnili sv\u00e9 zvyky, ani \u017eivotn\u00ed styl, pouze u\u017e\u00edvali ve\u010der 1 tabletu produktu AtheroControl po dobu 3 m\u011bs\u00edc\u016f.<\/p>\n\n\n\n

Nav\u00edc, AtheroControl prokazateln\u011b upravuje hladinu cholesterolu, triglycerid\u016f, cukru a jatern\u00edch parametr\u016f. Pr\u00e1v\u011b pro jeho c\u00edlen\u00fd \u00fa\u010dinek na endotel c\u00e9v a tak\u00e9 pozitivn\u00ed vliv na mno\u017estv\u00ed metabolick\u00fdch parametr\u016f si jej u n\u00e1s obl\u00edbilo i mnoho l\u00e9ka\u0159\u016f. AtheroControl je b\u011b\u017en\u011b dostupn\u00fd v l\u00e9k\u00e1rn\u00e1ch a \u010do\u010dk\u00e1ch, u\u017e\u00edv\u00e1 se 1 tableta ve\u010der. P\u0159i jeho pr\u016fm\u011brn\u00e9 cen\u011b, vych\u00e1z\u00ed denn\u00ed d\u00e1vka na m\u00e9n\u011b ne\u017e 1 euro. To ji\u017e stoj\u00ed za v\u00fdznamn\u00e9 sn\u00ed\u017een\u00ed rizika infarktu nebo mrtvice, zejm\u00e9na u lid\u00ed se zv\u00fd\u0161en\u00fdm krevn\u00edm tlakem.<\/p>\n\n\n\n

\n
AtheroControl m\u016f\u017eete koupit ZDE<\/strong><\/strong><\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n
\n
\"\"<\/figure>\n<\/div>\n\n\n
\n\n\n\n

MVDr. Peter Bla\u0161ko<\/p>\n\n\n\n

\u0159editel v\u00fdzkumu a v\u00fdvoje PHARCO GRANCREO<\/p>\n\n\n

\n
\"\"<\/figure>\n<\/div>","protected":false},"excerpt":{"rendered":"

P\u0159ed n\u011bkolika t\u00fddny vydal evropsk\u00fd statistick\u00fd \u00fa\u0159ad informaci, kter\u00e1 \u010cechov nepot\u011b\u0161ila. V pr\u016fm\u011bru se \u010ce\u0161i do\u017e\u00edvaj\u00ed ve zdrav\u00ed pouze do 61. roku sv\u00e9ho \u017eivota. To znamen\u00e1, \u017ee po dosa\u017een\u00ed tohoto v\u011bku se u n\u00e1s za\u010dnou objevovat z\u00e1va\u017en\u00e1 chronick\u00e1 onemocn\u011bn\u00ed. Pr\u016fm\u011brn\u00fd v\u011bk do\u017eit\u00ed mu\u017ee \u010cecha je 76 let, u \u017een je to asi o 4 roky […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","footnotes":""},"categories":[61],"tags":[],"class_list":["post-7911","post","type-post","status-publish","format-standard","hentry","category-uncategorized-cs"],"_links":{"self":[{"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/posts\/7911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/comments?post=7911"}],"version-history":[{"count":9,"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/posts\/7911\/revisions"}],"predecessor-version":[{"id":8705,"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/posts\/7911\/revisions\/8705"}],"wp:attachment":[{"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/media?parent=7911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/categories?post=7911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/old.grancreo.com\/cs\/wp-json\/wp\/v2\/tags?post=7911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}